Within the findings were several considerations for patients and payers: High costs for GLP-1 medications ranked as respondents top concern (followed by lack of control over who is prescribed the medications) 93% covered GLP-1s for management of diabetes in the previous plan year
Notably, one of the researchers was an employee of the SAG supplement manufacturer (Emothion, Gnosis S.p.A.) [1]
Progesterone's sleep-supporting effects therefore have downstream metabolic consequences that may meaningfully enhance GLP-1 responsiveness in ways that are easy to underestimate
Made in Australia
Ogata, T., Ideno, Y., Akai, M., Seichi, A., Hagino, H., Iwaya, T., Doi, T., Yamada, K., Chen, A.-Z., Li, Y., & Hayashi, K
Glutathione intravenously or orally - which is more effective